TITLE

Orlistat patients offered weight-loss support guidelines

AUTHOR(S)
Beyzarov, Elena Portyansky
PUB. DATE
May 2000
SOURCE
Drug Topics;5/1/2000, Vol. 144 Issue 9, p32
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Focuses on a health program from Hoffmann-La Roche company which helps patients taking the diet drug Xenical set realistic expectations on weight loss. Paraphernalia included in the starter kit; Information on the obesity management guidelines.
ACCESSION #
3235165

 

Related Articles

  • Xenical reworks its ads. Goetzl, David // Advertising Age;2/5/2001, Vol. 72 Issue 6, p3 

    The article reports that Hoffmann-La Roche's Xenical weight-loss drug will be promoted by Y&R Advertising with flight of awareness advertisements. The issue of potential side effects is viewed as obtrusive in the previous television campaign. The ads seek tom prompt discussion between patient...

  • Fighting fat.  // Drug Topics;6/2/97, Vol. 141 Issue 11, p30 

    Reports on the US Food and Drug Administration's approval of Hoffmann-La Roche's anti-obesity drug Xenical.

  • Roche resubmits Xenical NDA in face of phen-fen legal action.  // Medical Marketing & Media;Dec97, Vol. 32 Issue 12, p24 

    Reports that Hoffmann-La Roche has resubmitted its new drug application for the anti-obesity drug Xenical or orlistat at the US Food and Drug Administration. Mechanism of action of Xenical; Recall of the anti-obesity drugs Pondimin and Redux.

  • Viagra for the Thighs? Lemonick, Michael D.; Park, Alice // Time International (South Pacific Edition);05/10/1999, Issue 19, p58 

    Announces the release of the drug orlistat for weight loss in the United States. Drug to be manufactured by Hoffman-LaRoche as Xenical; Possible side effects; How the drug works; Importance of changing one's eating habits and exercising; Critics of putting the drug on the market.

  • Viagra for the Thighs? Lemonick, Michael D.; Park, Alice // Time;5/10/1999, Vol. 153 Issue 18, p72 

    Announces the release of the drug orlistat for weight loss in the United States. Drug to be manufactured by Hoffman-LaRoche as Xenical; Possible side effects; How the drug works; Importance of changing one's eating habits and exercising; Critics of putting the drug on the market.

  • New fat blocker?  // Joe Weider's Muscle & Fitness;Apr94, Vol. 55 Issue 4, p25 

    Reports on the development of the drug orlistat by Hoffman-La Roche for keeping some consumed fat from being broken down and used by the body. Recommended for the seriously overweight; Testing for the effectivity of orlistat.

  • Xenical's marketing appeal: Obesity is not in the mind, it is in the gut.  // Medical Marketing & Media;Jun99, Vol. 34 Issue 6, p18 

    Focuses on the marketing plans for the weight-loss substance called Orlistat from Hoffmann-La Roche Inc. Action of the drug on blocking dietary fat.

  • Orlistat approved.  // Healthy Weight Journal;Sep/Oct1999, Vol. 13 Issue 5, p66 

    Reports on the approval of the drug orlistat from Roche Laboratories for the treatment of obesity. Efficacy of the drug; Side effects of the drug.

  • Novel drug promotes weight loss, reduces obesity-related risks. Portyansky, Elena // Drug Topics;5/17/99, Vol. 143 Issue 9, p27 

    Focuses on Xenical, an antiobesity drug from Hoffmann-La Roche. Weight-loss benefits of orlistat; Side-effects of the drug; Information on minimizing the drug's side-effects. INSET: Tips to Remember.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics